Developer docs
API playgroundTry for free, no card

Search company profiles

INVIZA

Full company profile

uuid000bxkr

Namestring
INVIZA
Legal namestring
INVIZA Corporation
Websiteurl
inviza.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

INVIZA Corporation, operating as INVIZA Health, is an early-stage MedTech company developing the INVIZA CARE M1.0 unified Remote Patient Monitoring (RPM) and Digital Therapeutics (DTx) platform. The platform centers on self-charging smart insoles (InvizaSoles) that embed medical-grade optical sensors, force sensors, a 9-axis IMU, Bluetooth Low Energy, and LTE cellular radios, paired with patient and caregiver mobile apps (InvizaCare and InvizaSafe), a HIPAA- and DoD-secure cloud (InvizaCloud) running AI/ML predictive analytics (PredictiveWellness), and clinical web dashboards (InvizaPortal). The proprietary SmartPower system uses lead-free piezoelectric materials to convert the wearer's steps into electrical energy, eliminating external charging and addressing compliance failures common in wrist-based RPM devices.

INVIZA monetizes through a combined hardware-plus-software model, selling or licensing the insole hardware to enterprise buyers while generating recurring revenue from cloud-based RPM and DTx software services and clinical dashboards. Go-to-market is enterprise field sales targeting three primary verticals: healthcare providers (Hospital-at-Home, RPM, telehealth, concierge, senior and rural care), defense and military (readiness tracking, post-acute monitoring, VA applications), and athletics/sports medicine. Distribution is direct B2B with stated intent to build channel partnerships, augmented by heavy event-driven presence at HLTH, Health 2.0 Dubai, and DSI's DoD/VA Government HIT Summit.

The company is privately held, headquartered in Cambridge, Massachusetts, with a development and manufacturing center in Fairport (Rochester), New York. Leadership includes founder/CEO/CTO Robert G. Andosca, Ph.D. (prior founder of MicroGen Systems, acquired in 2017), surrounded by a board with credible industry signal — IEEE Medal of Honor recipient Kurt Petersen (co-founder Cepheid, SiTime), former Adidas VP Qaizar Hassonjee, and former Kansas Governor Dr. Jeffrey Colyer — while Kathy Ireland serves as Chief Global Brand Strategist via the kiSBN partnership. The firm is actively soliciting seed-stage capital from accredited angels and strategic investors and has not disclosed revenue.

Short descriptiontext

INVIZA Health is an early-stage MedTech company building self-charging smart insoles with embedded medical-grade optical sensors and edge/cloud AI for remote patient monitoring, digital therapeutics, and defense applications targeting healthcare providers, military, and athletics organizations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersFairport, United States
HQ citystring
Fairport
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
remote patient monitoring, wearable health sensors, digital therapeutics platform, self-charging insoles, hospital-at-home solutions
Industry5 codes
1Remote Patient Monitoring (RPM) Platforms & Services
CodeHLACAPAAPrimaryYes
2Chronic Care & Remote Patient Monitoring (RPM) Platforms
CodeHLALABAFPrimaryNo
3Hospital-at-Home & Acute-at-Home Remote Monitoring (step-down, escalation workflows)
CodeHLALAFAHPrimaryNo
4Care Coordination, Escalation & Clinical Workflow for RPM
CodeHLACAFAIPrimaryNo
5AI/Analytics for RPM (Risk Stratification, Alerts, Predictive)
CodeHLACAFAMPrimaryNo
NAICS code2 codes
  • Home Health Care Services621610
  • Services for the Elderly and Persons with Disabilities624120
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Remote Patient Monitoring Platform
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1INVIZA CARE M1.0 Platform
TypeHardware Sales
Description

Remote Health Monitoring platform comprising self-charging smart insoles (hardware), patient mobile apps, cloud platform, and clinical dashboards. Hardware sales combined with software/subscription components for healthcare providers, defense agencies, and athletics organizations in Hospital-at-Home, RPM, and DTx settings.

inviza.com
2RPM and DTx Software Services
TypeSubscription Recurring
Description

Software services for remote patient monitoring and digital therapeutics, including real-time data transmission to cloud platform, predictive analytics, and clinical dashboard access for healthcare providers.

inviza.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Operations, Infrastructure, Marketing or Sales
Pricing details1 tier
1B2B Enterprise Platform Pricing
ModelOtherBilling cadenceMulti-year contract
Notes

No specific pricing tiers publicly disclosed. Company is seeking B2B customers to engage with for Hospital-at-Home using self-charging RPM insoles, patient mobile app, and cloud solutions. Contact [email protected] for partnership inquiries.

inviza.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 8 records shown
1InvizaSoles™
Description

Self-charging, medical-grade smart insoles with AI/ML edge computing for vital sign measurement

inviza.com
+7 more records
Core offering1 text field

INVIZA sells the INVIZA® CARE M1.0 unified Remote Patient Monitoring (RPM) and Digital Therapeutics (DTx) platform comprising self-charging smart insoles (InvizaSoles™) with medical-grade optical sensors and edge AI/ML, patient and caregiver mobile apps (InvizaCare™, InvizaSafe™), a HIPAA- and DoD-secure cloud platform (InvizaCloud™) with predictive analytics, and clinical web dashboards (InvizaPortal™). The platform is sold B2B to healthcare providers, defense agencies, and athletic organizations for Hospital-at-Home, RPM, and continuous vital-sign monitoring use cases.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 40-49% of US hospitals fined $350M to $535M annually by CMS for readmissions
+3 more records
Product overview1 text field

INVIZA® offers the INVIZA® CARE M1.0 unified Remote Patient Monitoring (RPM) and Digital Therapeutics (DTx) platform designed for healthcare and defense applications. The platform integrates five core components: InvizaSoles™ smart insoles (self-charging wearable devices with medical-grade optical sensors and edge AI computing), InvizaSafe™ caregiver mobile app, InvizaCare™ patient mobile app, InvizaCloud™ HIPAA/DoD secure cloud platform with AI/ML analytics, and InvizaPortal™ web dashboards for clinical monitoring. The system enables real-time health monitoring of patients in hospital-at-home settings through continuous vital sign tracking, predictive analytics, and actionable DTx insights promoting physical activity for recovery.

Product and service3 records
1InvizaSoles™ Self-Charging Smart Insoles
CategoryWearable Medical Device Hardware
Description

Self-charging, medical-grade smart insoles with AI/ML edge computing that use piezoelectric materials to convert steps into energy. Features non-invasive optical sensors for measuring vital signs including heart rate, SpO2, body temperature, and a 9-axis IMU for movement tracking. Sold to healthcare providers, defense agencies, and athletic organizations for continuous remote patient monitoring.

2INVIZA® CARE M1.0 Platform
CategoryRemote Patient Monitoring and Digital Therapeutics Platform
Description

Unified Remote Patient Monitoring (RPM) and Digital Therapeutics (DTx) platform combining smart insoles, mobile apps (InvizaSafe, InvizaCare), cloud platform (InvizaCloud), and web dashboards (InvizaPortal) to enable real-time health monitoring of patients in Hospital-at-Home, RPM, and DTx settings for healthcare and defense customers.

3InvizaCloud™ HIPAA and DoD Secure AI/ML Cloud Platform
CategoryHealthcare Cloud Platform
Description

HIPAA- and DoD-secure AI/ML cloud computing platform that receives patient data via Bluetooth or LTE cellular, performs advanced analytics using artificial intelligence algorithms, and enables licensed medical professionals to remotely monitor patients with predictive analytics for readmission risk, fall prediction, and treatment optimization.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2020-07-21
Description

Partnership announced July 21, 2020. Kathy Ireland, Chair, CEO & Chief Designer of kathy ireland Worldwide, announced INVIZA as partner in her newly formed kiSBN. INVIZA designs FashTech MedTech fitness, health, predictive wellness and location trackers with products concealed within apparel, shoes and accessories. Kathy Ireland serves as Chief Global Brand Strategist for INVIZA Health.

Strategic tierSupportingTypeTechnology or Integration
Description

Military Intelligence, Software and Cybersecurity Experts providing DoD applications expertise. Quanterion Solutions is a Senior Program Manager affiliation for Major (ret.) Cully Patch who serves on INVIZA's Technical Advisory Board.

3Spectrum Ergonomics
Strategic tierSupportingTypeImplementation/ SI/ Consulting Partner
Description

Independent Beta-Testing Services provider for product testing and validation.

inviza.com
Strategic tierSupportingTypeOEM/ Whitelabel/ Licensing Partner
Description

High Volume, Low Cost Polyurethane Insoles Manufacturing partner for production scaling.

Strategic tierSupportingTypeTechnology or Integration
Description

Research partnership with Cornell CNF for energy harvesting technology development. INVIZA's SmartPower technology based on research completed in partnership with Cornell Energy Materials Center with funding from Army Research Laboratory, NSF/EPSCoR, NYSTAR, and NYSERDA.

Strategic tierSupportingTypeTechnology or Integration
Description

Research partnership with UVM for piezoelectric energy harvesting devices. Dr. Junru Wu (co-founder, MicroGen Systems) was Emeritus Professor at UVM. INVIZA technology based on world-renowned research from UVM and Cornell CNF partnership.

Strategic tierSupportingTypeGTM or Marketing Partner
Description

Qaizar Hassonjee, Ph.D. is a member of the Forbes Technology Council, providing thought leadership and visibility opportunities.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

INVIZA

Remote Patient Monitoring Platforminviza.com

INVIZA Health is an early-stage MedTech company building self-charging smart insoles with embedded medical-grade optical sensors and edge/cloud AI for remote patient monitoring, digital therapeutics, and defense applications targeting healthcare providers, military, and athletics organizations.

What INVIZA does

INVIZA Corporation, operating as INVIZA Health, is an early-stage MedTech company developing the INVIZA CARE M1.0 unified Remote Patient Monitoring (RPM) and Digital Therapeutics (DTx) platform. The platform centers on self-charging smart insoles (InvizaSoles) that embed medical-grade optical sensors, force sensors, a 9-axis IMU, Bluetooth Low Energy, and LTE cellular radios, paired with patient and caregiver mobile apps (InvizaCare and InvizaSafe), a HIPAA- and DoD-secure cloud (InvizaCloud) running AI/ML predictive analytics (PredictiveWellness), and clinical web dashboards (InvizaPortal). The proprietary SmartPower system uses lead-free piezoelectric materials to convert the wearer's steps into electrical energy, eliminating external charging and addressing compliance failures common in wrist-based RPM devices.

INVIZA monetizes through a combined hardware-plus-software model, selling or licensing the insole hardware to enterprise buyers while generating recurring revenue from cloud-based RPM and DTx software services and clinical dashboards. Go-to-market is enterprise field sales targeting three primary verticals: healthcare providers (Hospital-at-Home, RPM, telehealth, concierge, senior and rural care), defense and military (readiness tracking, post-acute monitoring, VA applications), and athletics/sports medicine. Distribution is direct B2B with stated intent to build channel partnerships, augmented by heavy event-driven presence at HLTH, Health 2.0 Dubai, and DSI's DoD/VA Government HIT Summit.

The company is privately held, headquartered in Cambridge, Massachusetts, with a development and manufacturing center in Fairport (Rochester), New York. Leadership includes founder/CEO/CTO Robert G. Andosca, Ph.D. (prior founder of MicroGen Systems, acquired in 2017), surrounded by a board with credible industry signal — IEEE Medal of Honor recipient Kurt Petersen (co-founder Cepheid, SiTime), former Adidas VP Qaizar Hassonjee, and former Kansas Governor Dr. Jeffrey Colyer — while Kathy Ireland serves as Chief Global Brand Strategist via the kiSBN partnership. The firm is actively soliciting seed-stage capital from accredited angels and strategic investors and has not disclosed revenue.

INVIZA firmographics

Firmographics
Name
INVIZA
Legal name
INVIZA Corporation
Website
https://inviza.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
INVIZA Health is an early-stage MedTech company building self-charging smart insoles with embedded medical-grade optical sensors and edge/cloud AI for remote patient monitoring, digital therapeutics, and defense applications targeting healthcare providers, military, and athletics organizations.
Ownership category
akta.pro rank

INVIZA industry classification

Industry
Product category
Remote Patient Monitoring Platform
NAICS
Home Health Care Services (621610), Services for the Elderly and Persons with Disabilities (624120)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Remote Patient Monitoring (RPM) Platforms & Services (HLACAPAA)
akta.pro secondary industries
Chronic Care & Remote Patient Monitoring (RPM) Platforms (HLALABAF), Hospital-at-Home & Acute-at-Home Remote Monitoring (step-down, escalation workflows) (HLALAFAH), Care Coordination, Escalation & Clinical Workflow for RPM (HLACAFAI), AI/Analytics for RPM (Risk Stratification, Alerts, Predictive) (HLACAFAM)

Keywords

  • Remote patient monitoring
  • Wearable health sensors
  • Digital therapeutics platform
  • Self-charging insoles
  • Hospital-at-home solutions

Where INVIZA is headquartered

Location

Headquarters

HQ city
Fairport
HQ country
United States
HQ region
North America

Offices2 records

Markets served

INVIZA business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. INVIZA CARE M1.0 Platform: Remote Health Monitoring platform comprising self-charging smart insoles (hardware), patient mobile apps, cloud platform, and clinical dashboards. Hardware sales combined with software/subscription components for healthcare providers, defense agencies, and athletics organizations in Hospital-at-Home, RPM, and DTx settings.
  2. RPM and DTx Software Services: Software services for remote patient monitoring and digital therapeutics, including real-time data transmission to cloud platform, predictive analytics, and clinical dashboard access for healthcare providers.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractB2B Enterprise Platform Pricing

Go-to-market motion3 records

Distribution channels2 records

Marketing channels6 records

INVIZA product offering

Product offering

Core offering

INVIZA sells the INVIZA® CARE M1.0 unified Remote Patient Monitoring (RPM) and Digital Therapeutics (DTx) platform comprising self-charging smart insoles (InvizaSoles™) with medical-grade optical sensors and edge AI/ML, patient and caregiver mobile apps (InvizaCare™, InvizaSafe™), a HIPAA- and DoD-secure cloud platform (InvizaCloud™) with predictive analytics, and clinical web dashboards (InvizaPortal™). The platform is sold B2B to healthcare providers, defense agencies, and athletic organizations for Hospital-at-Home, RPM, and continuous vital-sign monitoring use cases.

Product overview

INVIZA® offers the INVIZA® CARE M1.0 unified Remote Patient Monitoring (RPM) and Digital Therapeutics (DTx) platform designed for healthcare and defense applications. The platform integrates five core components: InvizaSoles™ smart insoles (self-charging wearable devices with medical-grade optical sensors and edge AI computing), InvizaSafe™ caregiver mobile app, InvizaCare™ patient mobile app, InvizaCloud™ HIPAA/DoD secure cloud platform with AI/ML analytics, and InvizaPortal™ web dashboards for clinical monitoring. The system enables real-time health monitoring of patients in hospital-at-home settings through continuous vital sign tracking, predictive analytics, and actionable DTx insights promoting physical activity for recovery.

Differentiator

Problem solved

Functional benefit

Brands

  • InvizaSoles™: Self-charging, medical-grade smart insoles with AI/ML edge computing for vital sign measurement
  • InvizaSafe™
  • InvizaCare™
  • InvizaCloud™
  • InvizaPortal™
  • SmartPower™
  • PredictiveWellness™
  • InvizaBLE Intelligence™

Products and services

  • InvizaSoles™ Self-Charging Smart Insoles Self-charging, medical-grade smart insoles with AI/ML edge computing that use piezoelectric materials to convert steps into energy. Features non-invasive optical sensors for measuring vital signs including heart rate, SpO2, body temperature, and a 9-axis IMU for movement tracking. Sold to healthcare providers, defense agencies, and athletic organizations for continuous remote patient monitoring.
  • INVIZA® CARE M1.0 Platform Unified Remote Patient Monitoring (RPM) and Digital Therapeutics (DTx) platform combining smart insoles, mobile apps (InvizaSafe, InvizaCare), cloud platform (InvizaCloud), and web dashboards (InvizaPortal) to enable real-time health monitoring of patients in Hospital-at-Home, RPM, and DTx settings for healthcare and defense customers.
  • InvizaCloud™ HIPAA and DoD Secure AI/ML Cloud Platform HIPAA- and DoD-secure AI/ML cloud computing platform that receives patient data via Bluetooth or LTE cellular, performs advanced analytics using artificial intelligence algorithms, and enables licensed medical professionals to remotely monitor patients with predictive analytics for readmission risk, fall prediction, and treatment optimization.

Quantifiable outcome

  • 40-49% of US hospitals fined $350M to $535M annually by CMS for readmissions
  • +3 more outcomes

Companies that use INVIZA

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles3 records

INVIZA technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature7 records

INVIZA partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and supporting.

  • Kathy Ireland Small Business Network (kiSBN)coreGTM or Marketing Partner · 21 July 2020Partnership announced July 21, 2020. Kathy Ireland, Chair, CEO & Chief Designer of kathy ireland Worldwide, announced INVIZA as partner in her newly formed kiSBN. INVIZA designs FashTech MedTech fitness, health, predictive wellness and location trackers with products concealed within apparel, shoes and accessories. Kathy Ireland serves as Chief Global Brand Strategist for INVIZA Health.
  • Quanterion SolutionssupportingTechnology or IntegrationMilitary Intelligence, Software and Cybersecurity Experts providing DoD applications expertise. Quanterion Solutions is a Senior Program Manager affiliation for Major (ret.) Cully Patch who serves on INVIZA's Technical Advisory Board.
  • Spectrum ErgonomicssupportingImplementation/ SI/ Consulting PartnerIndependent Beta-Testing Services provider for product testing and validation.
  • IdeastepsolesupportingOEM/ Whitelabel/ Licensing PartnerHigh Volume, Low Cost Polyurethane Insoles Manufacturing partner for production scaling.
  • Cornell NanoScale Science and Technology Facility (CNF)supportingTechnology or IntegrationResearch partnership with Cornell CNF for energy harvesting technology development. INVIZA's SmartPower technology based on research completed in partnership with Cornell Energy Materials Center with funding from Army Research Laboratory, NSF/EPSCoR, NYSTAR, and NYSERDA.
  • University of VermontsupportingTechnology or IntegrationResearch partnership with UVM for piezoelectric energy harvesting devices. Dr. Junru Wu (co-founder, MicroGen Systems) was Emeritus Professor at UVM. INVIZA technology based on world-renowned research from UVM and Cornell CNF partnership.
  • Forbes Technology CouncilsupportingGTM or Marketing PartnerQaizar Hassonjee, Ph.D. is a member of the Forbes Technology Council, providing thought leadership and visibility opportunities.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

INVIZA competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

INVIZA social profiles

Digital presence

INVIZA compliance and trust

Trust signal

Compliance2 records

INVIZA financial estimates

Financial estimate

Revenue estimate

Valuation estimate

INVIZA leadership team

Management profile

Number of profiles

Profiles12 records

INVIZA funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

INVIZA M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about INVIZA

What does INVIZA do?

INVIZA sells the INVIZA® CARE M1.0 unified Remote Patient Monitoring (RPM) and Digital Therapeutics (DTx) platform comprising self-charging smart insoles (InvizaSoles™) with medical-grade optical sensors and edge AI/ML, patient and caregiver mobile apps (InvizaCare™, InvizaSafe™), a HIPAA- and DoD-secure cloud platform (InvizaCloud™) with predictive analytics, and clinical web dashboards (InvizaPortal™). The platform is sold B2B to healthcare providers, defense agencies, and athletic organizations for Hospital-at-Home, RPM, and continuous vital-sign monitoring use cases.

Is INVIZA a public or private company?

INVIZA is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was INVIZA founded?

INVIZA was founded in 2020. It employs 11 to 50 people.

Where is INVIZA based?

INVIZA is headquartered in Fairport, United States, in the North America region.

How does INVIZA make money?

Two revenue lines are on record. INVIZA CARE M1.0 Platform is the primary driver. The others are RPM and DTx Software Services.

Does INVIZA have an API?

No public API is recorded for INVIZA.

What industry is INVIZA in?

INVIZA's product category is Remote Patient Monitoring Platform. Its primary akta.pro industry code is HLACAPAA, Remote Patient Monitoring (RPM) Platforms & Services, with a secondary code of HLALABAF, Chronic Care & Remote Patient Monitoring (RPM) Platforms. Its NAICS code is 621610 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals